Literature DB >> 19886805

Controlled release of bone morphogenetic protein-2 enhances recruitment of osteogenic progenitor cells for de novo generation of bone tissue.

Yu Kimura1, Nobuhiko Miyazaki, Naoki Hayashi, Satoru Otsuru, Katsuto Tamai, Yasufumi Kaneda, Yasuhiko Tabata.   

Abstract

The objective of this study was to evaluate the cellular contribution to the phenomenon of de novo generation of bone tissue induced by the controlled release of bone morphogenetic protein-2 (BMP-2). Gelatin hydrogels (2 mg) incorporating BMP-2 (3 microg) with different water contents were subcutaneously implanted into the back of enhanced green fluorescent protein-chimeric mice to induce the ectopic de novo generation of bone tissue. The hydrogels incorporating BMP-2 could release BMP-2 at different time profiles. When evaluated radiologically and histologically, the ectopic de novo generation of bone tissue was induced by the controlled release of BMP-2 from the hydrogels around the hydrogel-implanted site. The relative percentage number of green fluorescent protein- to osteocalcin-positive cells recruited into the de novo generated bone tissue depended on the BMP-2 release profile. The higher the percentage, the stronger was the de novo generation of bone tissue. These findings indicate that bone marrow-derived osteoblast progenitor cells were recruited from the blood circulation by BMP-2 release and consequently contributed to the ectopic de novo generation of bone tissue. It is conceivable that the local concentration of BMP-2 modifies the recruitment profile of progenitor cells with an osteogenic potential around the release site of BMP-2, resulting in regulated volume of de novo generated bone tissue.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19886805     DOI: 10.1089/ten.TEA.2009.0322

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  15 in total

Review 1.  Strategies for controlled delivery of growth factors and cells for bone regeneration.

Authors:  Tiffany N Vo; F Kurtis Kasper; Antonios G Mikos
Journal:  Adv Drug Deliv Rev       Date:  2012-02-04       Impact factor: 15.470

2.  Optimizing design and fabrication of microfluidic devices for cell cultures: An effective approach to control cell microenvironment in three dimensions.

Authors:  G Pagano; M Ventre; M Iannone; F Greco; P L Maffettone; P A Netti
Journal:  Biomicrofluidics       Date:  2014-08-22       Impact factor: 2.800

3.  Evaluation of rhBMP-2 and bone marrow derived stromal cell mediated bone regeneration using transgenic fluorescent protein reporter mice.

Authors:  Shalini V Gohil; Douglas J Adams; Peter Maye; David W Rowe; Lakshmi S Nair
Journal:  J Biomed Mater Res A       Date:  2014-03-03       Impact factor: 4.396

Review 4.  Novel approaches to bone grafting: porosity, bone morphogenetic proteins, stem cells, and the periosteum.

Authors:  Peter Petrochenko; Roger J Narayan
Journal:  J Long Term Eff Med Implants       Date:  2010

5.  Compression-Resistant Polymer/Ceramic Composite Scaffolds Augmented with rhBMP-2 Promote New Bone Formation in a Nonhuman Primate Mandibular Ridge Augmentation Model.

Authors:  Lauren A Boller; Archie A Jones; David L Cochran; Scott A Guelcher
Journal:  Int J Oral Maxillofac Implants       Date:  2020 May/Jun       Impact factor: 2.804

6.  Bone morphogenetic protein-2 release from composite hydrogels of oligo(poly(ethylene glycol) fumarate) and gelatin.

Authors:  Lucas A Kinard; Chia-Ye Chu; Yasuhiko Tabata; F Kurtis Kasper; Antonios G Mikos
Journal:  Pharm Res       Date:  2013-05-18       Impact factor: 4.200

7.  Osteocalcin positive CD133+/CD34-/KDR+ progenitor cells as an independent marker for unstable atherosclerosis.

Authors:  Andreas J Flammer; Mario Gössl; Robert Jay Widmer; Martin Reriani; Ryan Lennon; Darrell Loeffler; Sarah Shonyo; Robert D Simari; Lilach O Lerman; Sundeep Khosla; Amir Lerman
Journal:  Eur Heart J       Date:  2012-07-31       Impact factor: 29.983

Review 8.  Development of controlled drug delivery systems for bone fracture-targeted therapeutic delivery: A review.

Authors:  Yuchen Wang; Maureen R Newman; Danielle S W Benoit
Journal:  Eur J Pharm Biopharm       Date:  2018-02-19       Impact factor: 5.571

Review 9.  Supramolecular self-assembling peptides to deliver bone morphogenetic proteins for skeletal regeneration.

Authors:  Charlotte H Chen; Erin L Hsu; Samuel I Stupp
Journal:  Bone       Date:  2020-07-31       Impact factor: 4.398

Review 10.  Bioactive coatings for orthopaedic implants-recent trends in development of implant coatings.

Authors:  Bill G X Zhang; Damian E Myers; Gordon G Wallace; Milan Brandt; Peter F M Choong
Journal:  Int J Mol Sci       Date:  2014-07-04       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.